Gene Salkind - Jan 5, 2024 Form 4 Insider Report for Coeptis Therapeutics Holdings, Inc. (COEP)

Role
Director
Signature
/s/ Gene Salkind
Stock symbol
COEP
Transactions as of
Jan 5, 2024
Transactions value $
$8,004
Form type
4
Date filed
1/9/2024, 05:31 PM
Previous filing
Dec 19, 2023
Next filing
Jul 1, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COEP Common Stock Purchase $8K +11.6K +4.26% $0.69 284K Jan 5, 2024 Direct F1
holding COEP Common Stock 28.6K Jan 5, 2024 By Trust F2, F3
holding COEP Common Stock 4.05K Jan 5, 2024 By Trust F2, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 95,817 shares of common stock that are held as JTWROS with Catherine Salkind, (ii) 57,268 shares of common stock issuable upon exercise of currently exercisable warrants held as JTWROS with Catherine Salkind, (iii) 101,061 shares of common stock that are issuable upon currently exercisable warrants and (iv) 30,000 shares of common stock that are issuable upon exercise of options that are or will become exercisable in the next 60 days.
F2 These shares were not subject to a particular transaction during the dates covered by this Form 4 and are listed here to disclose the Reporting Person's holdings as required by Securities and Exchange Commission rules.
F3 The Marital Trust GST Subject U/W/O Leopold Salkind, for which the Reporting Person is the Trustee.
F4 Julian R Salkind Trust DTD 10/11/94, for which the Reporting Person is the Trustee.